New England Journal of Medicine · 2021 · 833 citations · 28 references
BNT162b2-induced protection against SARS-CoV-2 infection appeared to wane rapidly following its peak after the second dose, but protection against hospitalization and death persisted at a robust level for 6 months after the second dose. (Funded by Weill Cornell Medicine-Qatar and others.).
28
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin et al. · New England Journal of Medicine · 2020 · 15.1K citations · Full text
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
New England Journal of Medicine · 2020 · 10.4K citations · Full text
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Jamie Lopez Bernal, Nick Andrews, Charlotte Gower et al. · New England Journal of Medicine · 2021 · 3.1K citations · Full text
Victoria Hall, Sarah Foulkes, Ayoub Saei et al. · The Lancet · 2021 · 829 citations · Full text
Analysis of matched case-control studies
Neil Pearce · BMJ · 2016 · 766 citations · Full text